Correlation Between Defence Therapeutics and ChitogenX

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Defence Therapeutics and ChitogenX at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Defence Therapeutics and ChitogenX into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Defence Therapeutics and ChitogenX, you can compare the effects of market volatilities on Defence Therapeutics and ChitogenX and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Defence Therapeutics with a short position of ChitogenX. Check out your portfolio center. Please also check ongoing floating volatility patterns of Defence Therapeutics and ChitogenX.

Diversification Opportunities for Defence Therapeutics and ChitogenX

0.25
  Correlation Coefficient

Modest diversification

The 3 months correlation between Defence and ChitogenX is 0.25. Overlapping area represents the amount of risk that can be diversified away by holding Defence Therapeutics and ChitogenX in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ChitogenX and Defence Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Defence Therapeutics are associated (or correlated) with ChitogenX. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ChitogenX has no effect on the direction of Defence Therapeutics i.e., Defence Therapeutics and ChitogenX go up and down completely randomly.

Pair Corralation between Defence Therapeutics and ChitogenX

Assuming the 90 days horizon Defence Therapeutics is expected to generate 0.46 times more return on investment than ChitogenX. However, Defence Therapeutics is 2.15 times less risky than ChitogenX. It trades about -0.12 of its potential returns per unit of risk. ChitogenX is currently generating about -0.07 per unit of risk. If you would invest  201.00  in Defence Therapeutics on September 14, 2024 and sell it today you would lose (160.00) from holding Defence Therapeutics or give up 79.6% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Defence Therapeutics  vs.  ChitogenX

 Performance 
       Timeline  
Defence Therapeutics 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Defence Therapeutics are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable technical and fundamental indicators, Defence Therapeutics is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.
ChitogenX 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ChitogenX has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Defence Therapeutics and ChitogenX Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Defence Therapeutics and ChitogenX

The main advantage of trading using opposite Defence Therapeutics and ChitogenX positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Defence Therapeutics position performs unexpectedly, ChitogenX can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ChitogenX will offset losses from the drop in ChitogenX's long position.
The idea behind Defence Therapeutics and ChitogenX pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.

Other Complementary Tools

Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
CEOs Directory
Screen CEOs from public companies around the world
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Commodity Directory
Find actively traded commodities issued by global exchanges